Investigation for efficacy and safety of tau PET ligand [18F]AM-PBB3

Not Applicable

Recruiting

• Conditions: Alzheimer' s disease and mild cognitive impairment

• Registration Number: JPRN-UMIN000029084
• Lead Sponsor: ational Institute of Radiological Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-09-12
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who show obviously abnormal blood data at the 1st day of the study. 2. Subjects with organic brain complications/disorders (including traumatic brain injury, a history of symptomatic cerebral infarction, Parkinson's disease and similar conditions). 3. Patients with substance-related disorders (including drug abuse). 4. Subjects with severe physical complications/disorders or a history of such conditions and who are considered to be inappropriate for participation by the aforementioned doctors with responsibilities in this study. 5. Subjects with a pacemaker or other metallic medical device in the body (brain clip, bolts, etc.). 6. Subjects with tattoos. 7. Subjects with claustrophobia. 8. Pregnant, possibly pregnant or lactating women. 9. From the standpoint of radiation exposure from a nuclear medicine scan, subjects who have participated in other nuclear medicine scans as healthy volunteers in the 12 months prior to the start of this study. 10. Subjects who are considered to be inappropriate for participation by doctors with responsibilities in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified